Catalyst Wire Dossier Catalyst Wire Dossier

LEADER MUCUS RELIEF D

guaifenesin; pseudoephedrine hydrochloride · Cardinal Health 110, LLC. dba Leader
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LEADER MUCUS RELIEF D, covering 2022-02-01 to 2022-02-01. Get the full timeline:

Most recent: FDA Approved: LEADER MUCUS RELIEF D — Original Application (Cardinal Health 110, LLC. dba Leader)

See pricing